Daily Archives: 18 November 2026

Dietary Supplement Under Investigation for Possible Brain Health Benefits

Could a compound naturally produced by the gut help the brain cope with the demands of mental activity? Researchers at the University of Oklahoma have uncovered promising early evidence that urolithin A, a substance also sold as a dietary supplement, may improve blood circulation in the brain. In a clinical trial involving middle-aged adults with obesity, participants taking the supplement showed increased blood flow to a region associated with working memory. The findings, published in JAMA Network Open, raise new questions about the compound’s potential role in supporting brain health.

Urolithin A is produced when certain gut bacteria break down compounds found in foods such as pomegranates, strawberries and walnuts. However, not everyone produces the substance in equal amounts. Previous research suggests that the body’s ability to generate urolithin A declines with age and increasing body mass index. Scientists are particularly interested in its possible benefits for people with obesity, a condition associated with changes in blood vessel function that can restrict circulation, including blood flow to the brain.

To investigate, researchers recruited 50 adults between the ages of 40 and 64 for a randomised clinical trial. Over four weeks, participants received either 1,000 milligrams of urolithin A daily or a placebo. The team assessed blood vessel function and monitored changes in brain circulation while participants completed mentally demanding tasks. Those taking the supplement experienced a greater increase in cerebral blood flow during a challenging memory exercise than participants receiving the placebo.

The strongest response occurred in the left dorsolateral prefrontal cortex, an area involved in working memory. “The brain needs an adequate supply of blood to meet the demands of mental activity,” explained lead author Ana Clara da Costa Pinaffi Langley, an assistant professor of nutritional sciences at the University of Oklahoma. She said the increased circulation suggests urolithin A might help deliver oxygen and nutrients when the brain is working harder. Researchers described the trial as the first human study to report an effect of the compound on cerebrovascular function.

Yet increased blood flow did not translate into better cognitive performance. Participants showed no statistically significant improvements in memory or attention, while tests of blood vessel function in the arm also revealed no significant benefit. Study co-author Andriy Yabluchanskiy, an associate professor of neurosurgery, stressed that further investigation is needed to determine whether longer supplementation could produce meaningful improvements in cognitive function or other health outcomes.

The supplement was well tolerated throughout the trial, although the researchers cautioned against drawing broad conclusions from a small, single-site study lasting just four weeks. Larger trials with longer follow-up periods will be needed to establish whether the observed changes in brain circulation offer lasting benefits. For Langley, the broader ambition extends beyond improving performance on memory tests. The ultimate goal, she said, is to mitigate cognitive decline and help people enjoy more years of healthy living.

More information: Ana Clara da Costa Pinaffi-Langley et al, Urolithin A and Endothelial and Cerebrovascular Function in Middle-Aged Adults With Obesity – A Randomized Clinical Trial, JAMA Network Open. DOI: 10.1001/jamanetworkopen.2026.38047

Journal information: JAMA Network Open Provided by University of Oklahoma